Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway.
D000818:Animals; D002262:Carboxy-Lyases / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000201:enzymology*; D005968:Glutamate Decarboxylase / Q000378:metabolism*; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D009434:Neural Pathways / Q000201:enzymology; D051381:Rats; D013378:Substantia Nigra / Q000201:enzymology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D006892:Hydroxydopamines; D014446:Tyrosine 3-Monooxygenase; D002262:Carboxy-Lyases; D005968:Glutamate Decarboxylase